Roche’s virtual EHA 2023 event: Crovalimab in Hematology and Nephrology
Roche has hosted a virtual event on Monday, 12 June
| Agenda | |
|---|---|
| Welcome | Bruno Eschli, Head of Investor Relations |
| Roche hematology franchise and crovalimab deep-dive | Peter Ahnesorg, Franchise Head Hematology, Global Product Strategy |
| Key crovalimab data presented at EHA 2023 | Prof. Alexander Röth, MD, West German Cancer Center, University Hospital Essen |
| Roche nephrology franchise strategy and pipeline | Jay Garg, MD, Global Development Head of Nephrology and Rheumatology |
| Q&A |
Webinar Replay
Investors